Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.07 USD | +1.75% | +2.25% | -83.54% |
May. 14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
May. 10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.54% | 140M | |
+9.42% | 115B | |
+13.07% | 107B | |
-13.45% | 22.31B | |
-3.49% | 21.6B | |
-5.29% | 18.23B | |
-38.57% | 17.62B | |
+7.56% | 14.26B | |
+34.66% | 12.37B | |
-26.67% | 8.28B |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- RAPT Therapeutics' Shares Drop Tuesday Afternoon After Q4 Loss Widens